Related Experiment Video
Updated: Aug 5, 2026
07:48
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
PHB Biomanufacturing in China
Weinan Yang1, Fang Yang2, Weike Guo1
1School of Life Sciences, Tsinghua University, Beijing, China.
Advances in Biochemical Engineering/Biotechnology
|July 29, 2026
Summary
China
Area of Science:
- Biotechnology
- Polymer Science
- Environmental Science
Background:
- China's rapid advancement in polyhydroxyalkanoates (PHA) biomanufacturing, focusing on polyhydroxybutyrate (PHB).
- National "dual carbon" strategy driving innovation in sustainable materials.
- Development of novel halophilic chassis and next-generation industrial biotechnology (NGIB).
Purpose of the Study:
- To review the current landscape of NGIB-centered PHA/PHB production in China.
- To highlight alternative microbial chassis and industry players.
- To identify future research and development directions.
Main Methods:
- Review of scientific literature and industry reports on PHA biomanufacturing in China.
- Analysis of NGIB approaches, including halophilic chassis and unsterile fermentation.
- Assessment of C1 feedstock utilization, AI-assisted engineering, and circular economy aspects.
Main Results:
- Significant progress in translating PHA research to industrial scale, with PHB as a key product.
- Emergence of NGIB, enabling open, continuous, and unsterile PHA production.
- Identification of established producers, compounders, and emerging competitors in the Chinese market.
Conclusions:
- Future PHA development in China requires C1 feedstock, AI, and circularity.
- Managing high-salt process risks (corrosion, wastewater) is crucial for sustainable growth.
- China is positioned as a leader in advanced PHA biomanufacturing.
Related Concept Videos
01:27Bioplastics
Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:29Bioreactor Design and Operational System
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...